Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision

Dar Al Shifa Hospital

Status: Unknown

Conditions: Presbyopia

Treatments: Procedure: phacoemulsification

Study type: Interventional

Funder types: Other

Identifiers

NCT04904887

02282021065725

Details and patient eligibility

About

phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision

Full description

insertion of new intraocular lens enhanced for intermediate vision

Enrollment: 40 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• normal ocular examination apart from cataract.

Exclusion criteria

• previous ocular surgery.
• ocular pathology or corneal abnormalities.
• endothelial cell count below 2000 cells/mm2.
• corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Assessment of intermediate vision, defocus curve

Other group

Description:

Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 4 m, 80 cm, and 40 cm. he binocular defocus curve: The binocular defocus curve was done to evaluate the functional range of vision. The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.

Treatment:

Procedure: phacoemulsification